Updates are available Correction dated 2021-02-22

Article History

Accepted: 7 January 2021

First Online: 8 February 2021

Change Date: 22 February 2021

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s40271-021-00499-y

Declarations

:

: This work was funded by a grant from the Pharmaceutical Researchers and Manufacturers of America (PhRMA) Foundation Center of Excellence in Value Assessment Award. The views expressed in this manuscript were not contingent upon approval from or influenced by the PhRMA Foundation. Additional funding by the PhRMA supported this study.

: Julia F. Slejko reports grants from GSK Pharmaceuticals, Novartis Pharmaceuticals, and Takeda Pharmaceuticals and a teaching honorarium from Pfizer, all outside the submitted work. Susan dosReis reports grants from the National Institute of Mental Health, the Patient Centered Outcomes Research Institute, the US Food and Drug Administration, PhRMA Foundation, and GlaxoSmithKline. Yoon Duk Hong, Jamie L. Sullivan, and Robert M. Reed have no conflicts of interest that are directly relevant to the content of this article.

: The ESM provides the instrument used to collect all the data summarized at each phase of this formative work. This enables transparency and replication of this study in other populations. There are no software codes or analytical models related to this work.

: JFS and SDR obtained funding for this work, conceptualized the design and data collection, led the data analysis, contributed to the interpretation of the findings, and drafted and edited all aspects of the manuscript. JLS and RMR contributed to participant recruitment, data interpretation and analysis, and reviewed and edited all versions of the manuscript. YDH assisted with the data collection and the summation of the findings and reviewed and edited all versions of the manuscript.